Inventory increased 89.6%
Inventory changed +89.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$66.9M→$126.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FFIV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue moved 609 bp higher
Inventory / revenue changed +609 basis points from the comparable as-filed period.
8.58%→14.67%3 prior comparisons
Operating margin moved 50 bp lower
Operating margin changed -50 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
25.16%→24.65%3 prior comparisons
Gross margin moved 129 bp higher
Gross margin changed +129 basis points from the comparable as-filed period.
80.95%→82.25%3 prior comparisons
Revenue increased 10.9%
Revenue changed +10.9% from the comparable as-filed period.
$780.4M→$865.1M3 prior comparisons
Research & development increased 20.8%
Research & development changed +20.8% from the comparable as-filed period.
$136.3M→$164.7M3 prior comparisons
Operating income increased 8.6%
Operating income changed +8.6% from the comparable as-filed period.
$196.3M→$213.3M3 prior comparisons
Cash & equivalents increased 12.5%
Cash & equivalents changed +12.5% from the comparable as-filed period.
$1.4B→$1.6B2 prior comparisons
Net income increased 9.6%
Net income changed +9.6% from the comparable as-filed period.
$189.9M→$208.2M3 prior comparisons
Gross profit increased 12.6%
Gross profit changed +12.6% from the comparable as-filed period.
$631.7M→$711.5M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.